Skip to main content.

Daily Briefing: The First Stem Cell-Based Drug Is Approved

Daily Briefing: The First Stem Cell-Based Drug Is Approved

Picture of Raquel Orellana


Stem-cell-based drugs

Stem Cells:

 Canadian regulators have approved the first manufactured drug based on stem cells, New York Times' Andrew Pollack reports.  Osiris Therapeutics of Maryland manufactures the drug, which will be used to treat graft -versus-host disease in children.  

Hepatitis C: The Centers for Disease Control and Prevention has declared that being a baby boomer is a risk factor for hepatitis C and recommended that those in the age group get tested for the virus, the San Francisco Chronicle Reports.  

Medicaid: A report by the inspector general of the Department of Health and Human Services revealed that  the federal government gave the state of New York $700 million more than it needed in 2009 to care for residential developmental disability patients, reports Danny Hakim of the New York Times.

Junk Food: A new study found that students in high schools in California, which regulates the sale of junk food in school vending machines, eat fewer calories in school than do high school students in states that do not regulate school sales, reports Reuters' Kenny Grens.  

Health Care Law: Health official in 27 states are developing contingency plans to deal with "uninsurable" patients who would loose coverage if President Obama's health care law is overturned by the Supreme Court, the Washington Post Reports.

Want more from Reporting on Health? Join ussign up for our newsletterlike us on Facebook or follow us on Twitter. Check out our Tumblr, too!

Photo credit: Grumpy-Puddin via Flickr


Leave A Comment


The wave of attacks against Asian Americans and Pacific Islanders has been emotionally gutting for these communities. In our next webinar, we’ll examine the impact of the crisis on the mental health of Asian Americans, especially the women who are often targeted. Join us for a deep discussion to inform your coverage of the crisis and broader reporting on AAPI communities. Sign-up here!

As public health officials like to say, "COVID-19 isn't done with us." And journalists know that we're not done with COVID-19. Apply now for five days of stimulating discussions on the pandemic's disproportionate impact on people of color -- plus reporting and engagement grants of $2k-$10k and five months of mentoring while you work on an ambitious project.

Are you passionate about helping journalists understand and illuminate the social factors that contribute to health and health disparities at a time when COVID-19 has highlighted the costs of such inequities? Looking to play a big role in shaping journalism today in the United States? The USC Center for Health Journalism seeks an enterprising and experienced journalism leader for our new position of “Manager of Projects.” 



Follow Us



CHJ Icon